11/25
07:28 am
pbm
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program [Canadian Business Journal (Canada)]
Medium
Report
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program [Canadian Business Journal (Canada)]
11/25
07:00 am
pbm
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program
Low
Report
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program
11/20
07:50 am
pbm
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets [Yahoo! Finance]
High
Report
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets [Yahoo! Finance]
11/20
07:00 am
pbm
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets
High
Report
Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets
11/12
07:00 am
pbm
Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs
Medium
Report
Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs
11/6
07:00 am
pbm
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
High
Report
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
11/3
07:00 am
pbm
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment
High
Report
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment